NCT05918809View on ClinicalTrials.gov

Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL): Inpatient and Outpatient Settings

CompletedOBSERVATIONAL
Enrollment

1,031

Participants

Timeline

Start Date

July 25, 2021

Primary Completion Date

June 17, 2022

Study Completion Date

June 17, 2022

Conditions
Diffuse Large B-cell Lymphoma
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY